(19)
(11) EP 4 815 970 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24817524.2

(22) Date of filing: 28.11.2024
(51) International Patent Classification (IPC): 
A61K 36/185(2006.01)
A61K 33/06(2006.01)
A61P 13/12(2006.01)
 A61K 31/375(2006.01)
A61K 36/41(2006.01)
A61K 31/198(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 36/41; A61K 36/185; A61K 33/06; A61K 31/375; A61P 13/12; A61K 31/198
 
C-Sets:
  1. A61K 31/198, A61K 2300/00;
  2. A61K 36/41, A61K 2300/00;
  3. A61K 36/185, A61K 2300/00;
  4. A61K 33/06, A61K 2300/00;
  5. A61K 31/375, A61K 2300/00;
(86) International application number:
PCT/EP2024/083982
(87) International publication number:
WO 2025/114474 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 SE 2351365

(71) Applicant: Bioconcept AB
115 20 Stockholm (SE)

(72) Inventors:
  • FELLSTRÖM, Bengt
    741 92 Knivsta (SE)
  • NORDLANDER, Per
    167 65 Bromma (SE)

(74) Representative: Brann AB 
P.O. Box 3690 Sveavägen 63
103 59 Stockholm
103 59 Stockholm (SE)

   


(54) COMPOSITIONS FOR USE IN PREVENTING OR TREATING RENAL FAILURE AND ASSOCIATED DISORDERS